1 min read
January 2025: 43rd Annual J.P. Morgan Healthcare Conference
KBI Biopharma
Dec 17, 2024 11:17:12 AM
Join KBI Biopharma at The 43rd Annual J.P. Morgan Healthcare Conference
When: January 13-16, 2025
Where: San Francisco, California
KBI Biopharma is headed to San Francisco for 43rd Annual J.P. Morgan Healthcare Conference this January!
Schedule a meeting >>
Meet with the KBI Biopharma Team:
About KBI Biopharma:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Learn more about KBI Biopharma >>
About the Event:
This premier conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.
Let's Connect
Interested in setting up a time to talk with our team of experts at this event? Looking to follow up on a recent tech talk, presentation, or booth conversation? Let us know! We'd love to hear from you! Fill out the form below and we will be in touch.

April 2025: Festival of Biologics San Diego
Join KBI Biopharma at Festival of Biologics San Diego Booth # 722 When: April 23-24, 2025 Where: San Diego, California KBI Biopharma is headed to San...

April 2025: American Biomanufacturing Summit
Join KBI Biopharma at The American Biomanufacturing Summit Booth # 18 When: April 15-16, 2025 Where: San Francisco, CA KBI Biopharma is headed to San...